Allows prescription drug labels for mifepristone, misoprostol, and their generic alternatives to include the health care facility name instead of the.
This bill amends Maine's Prescription Drug Labeling Law to allow the name of the health care facility, instead of the prescriber's name, to appear on the label for mifepristone, misoprostol, and their generic alternatives. This change is made at the request of the prescribing practitioner. The law aims to provide an alternative to disclosing the prescriber's name on the label.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.